GLA
REGN icon

Great Lakes Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Great Lakes Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.6M Buy
16,928
+6,696
+65% +$4.56M 0.08% 147
2026
Q1 		$7.91M Buy
10,232
+8,399
+458% +$6.43M 0.07% 170
2025
Q4 		$1.41M Buy
1,833
+8
+0.4% +$5.43K 0.01% 476
2025
Q3 		$1.03M Buy
+1,825
New +$1.03M 0.01% 523
2024
Q4 		– Sell
-1,418
Closed -$1.49M – 867
2024
Q3 		$1.49M Sell
1,418
-357
-20% -$397K 0.01% 528
2024
Q2 		$1.87M Buy
+1,775
New +$1.72M 0.02% 474
2023
Q3 		– Sell
-1,759
Closed -$1.26M – 785
2023
Q2 		$1.26M Sell
1,759
-30
-2% -$23.1K 0.01% 499
2023
Q1 		$1.47M Buy
+1,789
New +$1.35M 0.01% 527

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Great Lakes Advisors's REGN Position: Q2 2026 in Review

Great Lakes Advisors increased its Regeneron Pharmaceuticals (REGN) stake by 65% in Q2 2026, buying an estimated $4.56M and bringing the position to 16,928 shares worth $10.6M. The position accounts for 0.08% of the portfolio, ranked #147.

Great Lakes Advisors first reported a position in REGN in Q1 2023 and has held it in 8 quarters since. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Great Lakes Advisors held 16,928 shares of Regeneron Pharmaceuticals worth $10.6M as of Q2 2026.
  • Great Lakes Advisors bought 6,696 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $4.56M.
  • Regeneron Pharmaceuticals made up 0.08% of Great Lakes Advisors's portfolio in Q2 2026, its #147 holding.
  • Great Lakes Advisors first reported a position in Regeneron Pharmaceuticals in Q1 2023 and has held it in 8 quarters since.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Great Lakes Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.